Affiliation:
1. Department of Pathology, University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria
2. Department of Pathology, University of Calabar Teaching Hospital, Calabar, Nigeria
Abstract
Objective: Cervical cancer is potentially preventable but still remains a leading cause of cancer mortality in in developing countries like Nigeria. Cytology-based screening programmes are difficult to maintain in these countries. Developing a cheap and reliable alternative is an important public health measure in these regions. This study was carried out to compare the utility of VIA and Pap smear as Cervical cancer screening methods in HIV-infected and non HIV-infected women.
Methodology: Between March, 2013 and March, 2014, 461 consenting women, comprising 231 HIV positive women (HPW) and 230 HIV negative women (HNW) were recruited and screened for cervical cancer using conventional Pap smear and VIA simultaneously in University of Uyo Teaching Hospital. The Pap smear findings were classified using the 2001 Bethesda system. Patients with a positive Pap smear or abnormal VIA findings were recalled for biopsy. The results of the two tests were compared using biopsy as the gold standard.
Results: The overall sensitivity, specificity, positive predictive value and negative predictive value for VIA were 100%,80%,76.9%, and 100%, respectively compared to 80%, 100%, 100%, and 88.2% for conventional Pap smear. Visual inspection of the cervix with acetic acid for cervical cancer screening is not specific but has a high negative predictive value.
Conclusion: This study does not support a “see-and-treat” approach in cervical cancer management using VIA only. In resource-challenged areas, VIA can be applied on a large scale basis in primary screening for cervical cancer so as to triage, women who will benefit from further evaluation before applying the appropriate treatment.
Publisher
Edelweiss Publications Inc
Reference35 articles.
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. Estimates of Worldwide burden of cancer in 2008, GLOBOCAN 2008 (2011) Int J Cancer 127: 2893-2917.
2. Ferlay J, Soerjomataran I, Ervikm M, Dikshit R, Eser R, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.11 (2013) International Agency for Research on Cancer, Lyon, France.
3. Ntekim A. Cervical cancer in sub-Sahara Africa. (2012) In: Topics on cervical cancer with an advocacy for prevention, Rajamanickan R (edtr) In-Tech Pp: 51-74.
4. Abd El All HS, Refaat A, Dandash K. Prevalence of Cervical neoplastic lesions in Egypt: National Cervical Cancer Screening Project (2007) Infectious agents and cancer 2:12.
5. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in Sub-Saharan Africa (2014) Int J Cancer 134:1389-1398.